Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II

PRG Science & Technology Co., Ltd. · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
neurofibromatosis type ii, nf2, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 843883
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.